Concepedia

Author

Parvez Mulani

Abbott Fund

Also Known As

Mulani, P., Mulani, P.M., Mulani, Parvez (author), P M Mulani, P Mulani, P. M. MULANI, P. M. Mulani, P. Mulani, P.M. Mulani, Parvez M Mulani

237

Publications

5.8K

Citations

40

H-Index

61

Concepts

All Affiliations

Abbott FundAnalysis Group (United States)AbbVie (United States)Abbott (United Kingdom)Abbott (United States)
PM

About

Parvez Mulani is an author at Abbott Fund specializing in medicine, dermatology, and gastroenterology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

20

27

2.5K

2

Health Sciences

3

3

351

3

Public Health

3

3

214

4

Nursing

1

1

14

5

Diabetes

1

1

59

Parvez Mulani

×

53

Publications

4.8K

Citations

36

H-Index

YearCitations

Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa

Alexa B. Kimball, Francisco A. Kerdel, David R. Adams,

Annals of Internal Medicine

2012

406

Effects of Adalimumab Therapy on Incidence of Hospitalization and Surgery in Crohn's Disease: Results From the CHARM Study

Brian G. Feagan, Remo Panaccione, William J. Sandborn,

Gastroenterology

2008

371

Comparative Effectiveness Without Head-to-Head Trials

James Signorovitch, Eric Q. Wu, Andrew P. Yu,

PharmacoEconomics

2010

353

Adalimumab Induces Deep Remission in Patients With Crohn's Disease

Jean‐Frédéric Colombel, Paul Rutgeerts, William J. Sandborn,

Clinical Gastroenterology and Hepatology

2013

245

Estimating Clinically Meaningful Changes for the Functional Assessment of Cancer Therapy—Prostate: Results from a Clinical Trial of Patients with Metastatic Hormone-Refractory Prostate Cancer

David Cella, Michael B. Nichol, David T. Eton,

Value in Health

2008

211

Effects of Adalimumab Maintenance Therapy on Health-Related Quality of Life of Patients With Crohn's Disease: Patient-Reported Outcomes of the CHARM Trial

Edward V. Loftus, Brian G. Feagan, Jean‐Frédéric Colombel,

The American Journal of Gastroenterology

2008

210

Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment

Alexa B. Kimball, Gregor B. E. Jemec, Min Yang,

British Journal of Dermatology

2014

202

The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: A randomized clinical trial

Alan Menter, Matthias Augustin, James Signorovitch,

Journal of the American Academy of Dermatology

2010

194

Risks of developing psychiatric disorders in pediatric patients with psoriasis

Alexa B. Kimball, Eric Q. Wu, Annie Guérin,

Journal of the American Academy of Dermatology

2012

194

The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn’s disease who failed prior infliximab therapy

Simon Lichtiger, DG Binion, Douglas C. Wolf,

Alimentary Pharmacology & Therapeutics

2010

184

Page 1